Marella Thorell - Jun 9, 2022 Form 4 Insider Report for Vallon Pharmaceuticals, Inc. (GRI)

Role
Director
Signature
/s/ David Baker, attorney-in-fact
Stock symbol
GRI
Transactions as of
Jun 9, 2022
Transactions value $
$0
Form type
4
Date filed
6/10/2022, 01:31 PM
Previous filing
Mar 23, 2022
Next filing
Nov 1, 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GRI Stock Option (Right to Buy) Award $0 +7.5K $0.00 7.5K Jun 9, 2022 Common Stock 7.5K $0.51 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests in four equal quarterly installments such that the stock option is fully vested on the first anniversary of the date of grant.